[Federal Register Volume 80, Number 188 (Tuesday, September 29, 2015)]
[Notices]
[Page 58478]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-24656]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Meeting of the Advisory Committee on Immunization Practices
(ACIP)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announce the following meeting of the aforementioned
committee.
Time and Date: 8:00 a.m.-6:00 p.m., EDT, October 21, 2015.
Place: CDC, Tom Harkin Global Communications Center, 1600 Clifton Road
NE., Building 19, Kent ``Oz'' Nelson Auditorium, Atlanta, Georgia
30329.
Status: Open to the public, limited only by the space available. Time
will be available for public comment. The public is welcome to submit
written comments in advance of the meeting. Comments should be
submitted in writing by email to the contact person listed below. The
deadline for receipt October 12, 2015. All requests must contain the
name, address, and organizational affiliation of the speaker, as well
as the topic being addressed. Written comments should not exceed one
single-spaced typed page in length and delivered in 3 minutes or less.
Please note that the public comment period may end before the time
indicated, following the last call for comments. Members of the public
who wish to provide public comments should plan to attend the public
comment session at the start time listed. Written comments received in
advance of the meeting will be included in the official record of the
meeting.
The meeting will be webcast live via the World Wide Web; for
instructions and more information on ACIP please visit the ACIP Web
site: http://www.cdc.gov/vaccines/acip/index.html.
Purpose: The committee is charged with advising the Director, CDC, on
the appropriate use of immunizing agents. In addition, under 42 U.S.C.
1396s, the committee is mandated to establish and periodically review
and, as appropriate, revise the list of vaccines for administration to
vaccine-eligible children through the Vaccines for Children (VFC)
program, along with schedules regarding the appropriate periodicity,
dosage, and contraindications applicable to the vaccines. Further,
under provisions of the Affordable Care Act, at section 2713 of the
Public Health Service Act, immunization recommendations of the ACIP
that have been adopted by the Director of the Centers for Disease
Control and Prevention and appear on the CDC immunization schedules
must be covered by applicable health plans.
Matters For Discussion: The agenda will include discussions on: child
and adolescent immunization schedule; adult immunization schedule;
meningococcal vaccines; human papillomavirus vaccines; influenza;
combination vaccine (pediatric hexavalent vaccine (DTaP-IPV-Hib-HepB);
cholera vaccine; Japanese encephalitis vaccine; Ebola vaccine trial
update and vaccine supply. Recommendation votes are scheduled for child
and adolescent immunization schedule and adult immunization schedule.
Agenda items are subject to change as priorities dictate.
Contact Person For More Information: Stephanie Thomas, National Center
for Immunization and Respiratory Diseases, CDC, 1600 Clifton Road NE.,
MS-A27, Atlanta, Georgia 30329, telephone 404/639-8836; Email
[email protected].
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities for
both the Centers for Disease Control and Prevention and the Agency for
Toxic Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention (CDC).
[FR Doc. 2015-24656 Filed 9-28-15; 8:45 am]
BILLING CODE 4163-18-P